Inno-Gene S.A. provides genetic diagnostic solutions in Poland. It is involved in the research and diagnostic center implementation; and the provision of technologies in the field of DNA analysis. The company also develops and implements diagnostic algorithm for prevention and personalization of treatment of HPV-dependent solid tumors. In addition, it provides DNA analysis and genetic diseases diagnostic service based on NGS technology. Inno-Gene S.A. was incorporated in 2010 and is headquartered in Poznan, Poland.
Stock data | 2024 | Change |
---|---|---|
Price | $0.764699344225853 | N/A |
Market Cap | $4.36M | N/A |
Shares Outstanding | 5.70M | N/A |
Employees | 10.00 | N/A |